Both in Pharmaceuticals
Spyre Therapeutics vs Corcept Therapeutics
Over the past year SYRE returned +308.0% and CORT returned +4.4%; their daily moves had a correlation of 0.14.
SYRE +308.0% CORT +4.4%Growth of $1, one year, split-adjusted
| Metric | SYRE | CORT |
|---|---|---|
| Price | $97.02 | $77.45 |
| Market cap | $9.07B | $8.37B |
| Today | −2.27% | −5.47% |
| 1 month | +21.1% | −35.2% |
| 6 months | +32.9% | +48.5% |
| Year to date | +196.2% | +122.5% |
| 1 year | +308.0% | +4.4% |
| Revenue growth (YoY) | — | +31.7% |
| Gross margin | — | 98.4% |
| Net margin | — | 16.8% |
| P/E (TTM) | — | 153.6× |
| Price / sales | — | 10.1× |
| Net cash | $1.07B | $308.2M |
| Dividend yield | — | — |
| Volatility (60d) | 59.2% | 60.1% |
| Short % of float | 15.6% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).